"Designing Growth Strategies is in our DNA"

U.S. Bleeding Disorder Testing Market Size, Share & Industry Analysis, By Product (Reagents & Consumables and Instruments), By Indication (Hemophilia A, Hemophilia B, Von Willebrand Disease, Idiopathic Thrombocytopenic Purpura, and Others), By End-user (Hospitals & Clinics, Diagnostic Centers, and Others), and Country Forecast, 2024-2032

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI109963

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Bleeding Disorders, 2022/2023
    2. New Product Launches, By Key Players
    3. Key Industry Developments- Mergers, Acquisitions, Partnerships, etc.
    4. Technological Advancements in Bleeding Disorders Testing
    5. Impact of COVID-19 on the Market
  5. U.S. Bleeding Disorders Testing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Reagents & Consumables
      2. Instruments
    2. Market Analysis, Insights and Forecast – By Indication
      1. Hemophilia A
      2. Hemophilia B
      3. Von Willebrand Disease
      4. Idiopathic Thrombocytopenic Purpura (ITP)
      5. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Siemens Healthcare GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. HORIBA Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Sysmex Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Abbott
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Atlas Medical GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. HYPHEN BioMed
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Precision Biologics
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Bleeding Disorders, 2022/2023
    2. New Product Launches, By Key Players
    3. Key Industry Developments- Mergers, Acquisitions, Partnerships, etc.
    4. Technological Advancements in Bleeding Disorders Testing
    5. Impact of COVID-19 on the Market
  5. U.S. Bleeding Disorders Testing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Reagents & Consumables
      2. Instruments
    2. Market Analysis, Insights and Forecast – By Indication
      1. Hemophilia A
      2. Hemophilia B
      3. Von Willebrand Disease
      4. Idiopathic Thrombocytopenic Purpura (ITP)
      5. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Siemens Healthcare GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. HORIBA Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Sysmex Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Abbott
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Atlas Medical GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. HYPHEN BioMed
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Precision Biologics
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: U.S. Bleeding Disorders Testing Market Revenue Breakdown (USD million, %), By Product Type, 2023 & 2032

Figure 2: U.S. Bleeding Disorders Testing Market Value Share (%), by Product Type, 2023 & 2032

Figure 3: U.S. Bleeding Disorders Testing Market Value Share (%), by Indication, 2023 & 2032

Figure 4: U.S. Bleeding Disorders Testing Market Value Share (%), by End User, 2023 & 2032

Figure 5: U.S. Bleeding Disorders Testing Market Share (%), By Company, 2023

Table 1: U.S. Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Product Type, 2019-2032

Table 2: U.S. Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Indication, 2019-2032

Table 3: U.S. Bleeding Disorders Testing Market Revenue (USD million) Forecast, by End User, 2019-2032

U.S. Bleeding Disorder Testing Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports